Literature DB >> 17301674

Expression of inflammatory genes in the primary visual cortex of late-stage Alzheimer's disease.

Jian-Guo Cui1, James M Hill, Yuhai Zhao, Walter J Lukiw.   

Abstract

Alzheimer's disease is associated with progressively dysfunctional gene expression in the limbic system of the brain. The thalamus and primary visual cortex are thought to be initially spared of Alzheimer-type changes that ravage the association neocortex. In this study, using DNA arrays and Western immunoassay, gene expression patterns were examined in the thalamus and primary visual cortex of moderate-stage and late-stage Alzheimer's disease and age-matched controls using a set of proinflammatory genes known to be upregulated in the temporal lobe neocortex and hippocampus of moderate-stage Alzheimer's disease. The data indicate that, in late-stage Alzheimer's disease, proinflammatory and proapoptotic gene expression spreads into the primary visual sensory cortex. This upregulation of pathological gene expression could be, in part, responsible for the visual disturbances associated with end-stages of the Alzheimer process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301674     DOI: 10.1097/WNR.0b013e32801198bc

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  27 in total

1.  Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA.

Authors:  Walter J Lukiw; Peter N Alexandrov; Yuhai Zhao; James M Hill; Surjyadipta Bhattacharjee
Journal:  Neuroreport       Date:  2012-07-11       Impact factor: 1.837

2.  Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD).

Authors:  Walter J Lukiw; Bhattacharjee Surjyadipta; Prerna Dua; Peter N Alexandrov
Journal:  Int J Biochem Mol Biol       Date:  2012-03-20

Review 3.  Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.

Authors:  Puneet Talwar; Juhi Sinha; Sandeep Grover; Chitra Rawat; Suman Kushwaha; Rachna Agarwal; Vibha Taneja; Ritushree Kukreti
Journal:  Mol Neurobiol       Date:  2015-09-09       Impact factor: 5.590

4.  Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.

Authors:  Nicole Maphis; Guixiang Xu; Olga N Kokiko-Cochran; Shanya Jiang; Astrid Cardona; Richard M Ransohoff; Bruce T Lamb; Kiran Bhaskar
Journal:  Brain       Date:  2015-03-31       Impact factor: 13.501

5.  LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia.

Authors:  Ludmila Belayev; Larissa Khoutorova; Kristal Atkins; William C Gordon; Julio Alvarez-Builla; Nicolas G Bazan
Journal:  Exp Neurol       Date:  2008-08-28       Impact factor: 5.330

6.  An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells.

Authors:  Walter J Lukiw; Yuhai Zhao; Jian Guo Cui
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

7.  Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease.

Authors:  Peter N Alexandrov; Aileen Pogue; Surjyadipta Bhattacharjee; Walter J Lukiw
Journal:  Neuroreport       Date:  2011-08-24       Impact factor: 1.837

8.  Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD).

Authors:  Walter J Lukiw
Journal:  Expert Opin Emerg Drugs       Date:  2012-03-23       Impact factor: 4.191

Review 9.  The role of epigenetics in age-related macular degeneration.

Authors:  M Gemenetzi; A J Lotery
Journal:  Eye (Lond)       Date:  2014-09-19       Impact factor: 3.775

10.  Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells.

Authors:  Anja Boetkjaer; Merete Boedker; Jian-Guo Cui; Yuhai Zhao; Walter J Lukiw
Journal:  Neurosci Lett       Date:  2007-08-31       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.